GENOMMA LAB ANNOUNCES CEO TRANSITION
COMPANY BEGINS A NEW STAGE OF ACCELERATION MEXICO CITY, Sept. 17, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Latin America with operations in 18...
Read more »